Search
for
Sort by
Research 211–240 of 1000+
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Uncovering the complex relationship between balding, testosterone and skin cancers in men
- Skin aging as a mechanical phenomenon: The main weak links
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Particulate matter 2.5 damages skin cells by inducing oxidative stress, subcellular organelle dysfunction, and apoptosis
- The PDGF/PDGFR pathway as a drug target
- Gender differences in skin: A review of the literature
- Dermatological adverse events with taxane chemotherapy
- Effects of Turmeric (<i>Curcuma longa</i>) on Skin Health: A Systematic Review of the Clinical Evidence
- Genetic prediction of male pattern baldness
- Isotretinoin treatment of acne and related disorders: An update
- Medical and surgical therapies for alopecias in black women
- Physiologic functions of PP2A: Lessons from genetically modified mice
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Scalp Dermoscopy or Trichoscopy
- Oestrogen functions in skin and skin appendages
- Dissecting the microenvironment around biosynthetic scaffolds in murine skin wound healing
- The Modulatable Stem Cell Niche: Tissue Interactions during Hair and Feather Follicle Regeneration
- Serum Ferritin and Vitamin D in Female Hair Loss: Do They Play a Role?
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Hirsutism and the Variable Response of the Pilosebaceous Unit to Androgen
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Cutaneous Manifestations of Eating Disorders
- Adverse Cutaneous Reactions to Mood Stabilizers
- Idiopathic Hirsutism*
- Cicatricial (Scarring) Alopecias
- Update on the dermatologic use of systemic glucocorticosteroids
- The Clinical Presentation of Systemic Lupus Erythematosus
- Hair removal using an Nd: YAG laser system.